Atrial FibrillationCREED AFNCT06042231
Impact of Cardiac Prehabilitation, REhabilitation and Patient EDucation on Outcomes in Patients Undergoing First-time AF Ablation
A study testing Exercise Intervention and Education Intervention in people with Atrial Fibrillation, run by University Hospitals Coventry and Warwickshire NHS Trust at 1 site in United Kingdom.
Trial summary
Atrial fibrillation (AF) is a term used to describe an irregular, and often very rapid, heartbeat. AF increases the risk of a number of diseases associated with the heart and cardiovascular system. Ablation is a procedure to treat AF. Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Atrial Fibrillation
- What is being tested?
- Exercise Intervention and Education Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 107 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 2 Nov 2023to 30 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- All patients listed for a first-time AF ablation procedure
- Patients aged ≥18 years
Who cannot join
- Pregnancy
- Lack of capacity to consent and participate
- Presence of contraindications or limiting physical or mental health co-morbidity preventing travel, safe exercise, or productive engagement with the trial
- Unable to access online exercise and support sessions from home
- Participating in a research trial that will impact on their standard AF ablation procedure
- Unable to understand basic spoken and written English
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
University Hospital Coventry and Warwickshire NHS Trust
Coventry, West Midlands, CV22DX
About this study
Atrial fibrillation (AF) is a term used to describe an irregular, and often very rapid, heartbeat. AF increases the risk of a number of diseases associated with the heart and cardiovascular system. Ablation is a procedure to treat AF. It uses small burns or freezes to cause some scarring on the inside of the heart to help break up the electrical signals that cause irregular heartbeats. This can help the heart maintain a normal rhythm.
Currently patients who are referred for AF ablation do not receive any additional support as part of standard care to improve the outcomes of their ablation procedure. Whereas cardiac rehabilitation is a recognised part of comprehensive care for coronary heart disease patients (patients whose hearts struggle to receive blood), with exercise and education consistently identified as central elements to their rehabilitation. This treatment is not yet recommended for AF ablation patients.
Therefore, the CREED AF Study is investigating whether a tailored comprehensive exercise and education intervention can improve outcomes in patients who are undergoing first time AF ablation. Central to the CREED AF study is the 'prehabilitation' intervention, whereby exercise and education training will be conducted before AND after AF ablation. 106 participants is the target recruitment, they will be randomised to either receive the CREED AF intervention (exercise and education intervention before AND after AF ablation) or a standard care (control) group. The standard care group will receive a one off 1-to-1 patient education session with a trained practitioner before their AF ablation procedure. This research study does not affect the AF ablation procedure that patients will have as part of their standard of care.
Read the detailed description
This is a single centre, prospective, randomised controlled trial. The CREED AF study will run from University Hospitals Coventry \& Warwickshire (UHCW) NHS Trust. There will be collaboration with Atrium Health, a non-profit exercise rehabilitation centre located in Coventry, UK. Atrium Health was founded by frontline NHS clinical staff to provide people with tailored exercise and education programmes. Patients with AF who are referred for first-time AF ablation at University Hospitals Coventry \& Warwickshire NHS Trust will be recruited to the trial. The aim is to explore the effectiveness of a tailored comprehensive cardiac rehabilitation programme (both before and after the planned AF ablation) comprising of an exercise programme and patient education programme incorporating lifestyle behaviour change (CREED AF intervention), compared to standard care (control arm).
The CREED AF intervention will involve a cardiac pre/rehabilitation exercise training programme combined with a patient education programme.
To ensure generalisability for future trials, provisions will be based on current delivery models of cardiac rehabilitation in cardiovascular diseases. A 6-8-week supported programme of 2-3 times weekly exercise will be delivered with an initial individual assessment for each patient randomised to the intervention. Participants will attend a one-to-one appointment with a 'CREED AF practitioner' (specialist cardio-pulmonary clinical exercise physiologist or physiotherapist) for the assessment of medical history, medication, clinical parameters, physical activity history and discussion of participant goals, expectations, fears, and concerns. Patients randomised to the CREED AF intervention will have access to both existing cardio-pulmonary rehabilitation programmes at the Atrium Health Centre, Coventry (i.e., they will exercise alongside people with a range of cardio-pulmonary disorders at already running sessions) AND instructor-led, at home workout sessions that will take place live over a video conferencing software. It is anticipated that participants randomised to the CREED AF intervention will choose to receive a hybrid of the two approaches to reduce travel constraints of getting to and from the Atrium Health Centre, and to work more flexibly around a participant's working/personal life. To maximise accessibility and resource, whilst ensuring benefits are retained, the CREED AF intervention will be delivered as a 'rolling' programme. Participants randomised to the CREED AF intervention can immediately join existing cardio-pulmonary rehabilitation exercise programmes rather than waiting for the recruitment of sufficient numbers to form a discrete group of trial participants.
Cardiac pre/rehabilitation This will be a tailored, individualised exercise programme within pre-specified parameters. Clinical information, data from the exercise assessment, and patient-centred goal setting will be used to devise a safe and effective exercise prescription which can be performed either using pre-existing cardiopulmonary exercise groups at Atrium Health or using the instructor-led online classes that will be available. Exercise guidance, specific to AF, will be delivered on an individual basis during a 1-to-1 familiarisation exercise session in the first week of the programme, and reinforced throughout, by clinical staff. Familiarisation sessions, conducted within the cardiopulmonary rehabilitation programmes will enable participants to build their confidence and there will be optimisation of the exercise prescribed.
The cardiac rehabilitation can be undertaken within existing cardio-pulmonary rehabilitation programmes delivered by NHS clinical staff. Up to 3 times weekly, one hour, exercise sessions for 6-8 weeks before and for 6-8 weeks after AF ablation, with a quantifiable and progressive dose of individualised, multi-modal, aerobic, muscular strength, endurance and 'functional fitness' exercise. Adequate warm-up and cool-down will be incorporated. Intensity can be monitored and adjusted using heart rate (where appropriate), rating of perceived exertion, and dyspnoea scale. There is normally a 1-2-week recovery period after an AF ablation procedure to allow for femoral access site wound healing. Only after the participant has completed this 2-week recovery period will they restart their exercise intervention.
The exercise component will be optimised to be appropriate for a broad spectrum of patients including frailer, deconditioned, low-mobility, exercise-naive participants. Conventional gym exercise will be combined with 'functional fitness' training. The programme will be highly adaptable to allow personalisation to lower or higher ability participants, whilst ensuring safety and efficacy. This is widespread practice within cardio-pulmonary rehabilitation programmes in the UK.
In addition to treadmills, cycles, and rowing ergometers, readily available functional fitness equipment such as steps, floor agility ladders, low rise balance beams, power bags, plyometric boxes, balls (throw/bounce) etc will be made use of. A range of body weight exercises for online sessions at home will also be utilised. Central to our intervention is the expertise and experience of the specialist CREED AF practitioner who will ensure holistic, safe, individualised, and effective exercise training.
Education, behavioural and lifestyle AF risk Factor Modification Support The education programme will be delivered in 1-to-1 sessions with a delegated and qualified member of the research team which can be delivered either face-to-face or via an online video conferencing software. The education session will be delivered as part of the CREED AF intervention. Changing behaviours can be difficult and the importance of psychological support in AF patients is recognised. Therefore, discussions with individuals on motivation to change, barriers to change, goal setting and problem-solving to build self-efficacy and encourage behaviour change, adherence, and compliance to risk factor modification will be incorporated. Every second week (a total of 6 1-to-1 education sessions, 3 sessions in prehabilitation before ablation, and 3 sessions in rehabilitation after ablation), before or after exercise, participants will receive a 1-to-1 30-minute behavioural and motivational session with the aim of improving short- and long-term adherence to exercise and lifestyle modification goals. The aim of this will be to provide help to patients to manage lifestyle risk factors. These will include reduction of alcohol consumption to less than 2 Units per day (in line with current UK government guidelines), ensure good blood pressure control in line with international guidelines (<140/85mmHg), provide smoking cessation support, help with good diabetes control, advice on weight reduction management (through diet and exercise) and identification and treatment of obstructive sleep apnoea (OSA). Patients in the intervention group will be provided with written materials, including but not limited to a patient workbook and publicly available patient information leaflets, with sign-posting to support groups as applicable to each individual.
The CPET will be performed by both the control and intervention groups at baseline and 10 weeks (±2 weeks) post-ablation. The test will be used to assess exercise capacity and will give an indicator of the participant's cardiorespiratory fitness. The tests will be performed at UHCW's respiratory laboratory. The lab is UKAS accredited to IQIPS standard to perform CPET. The local UHCW standard operating procedure for CPET will be followed for all participants during their VO2peak test. This information is available in full detail in a separate document, but briefly:
- The participant will have their height and weight measured and information about the current medications collected.
- They will have the procedure explained to them in full detail and any questions they have will be answered.
- A spirometry measurement of forced vital capacity will be obtained before the CPET begins.
- A 12-lead ECG will be attached to the participant.
- A Hans Rudolph face mask will be fitted to the participant and baseline data collected.
- A blood pressure cuff and pulse oximeter will be attached with measurements taken at baseline and during the test.
- The exercise protocol will begin with increasing exercise intensity until the participant feels they cannot continue, when cadence falls by 5% or more or when the individual leading the exercise test requests it to be stopped.
- Recovery period involving low intensity exercise.
Participants who are randomised into the control group will also receive a 30-minute 1-to-1 education session (remotely or in person) from a CREED AF practitioner before their AF ablation to go through the risk factors of AF and what they can do to improve their health. The session will involve a discussion with the participant around risk factors related to AF and recommendations for what actions the participant should take to minimise these factors, sign-posting to publicly available patient information leaflets (e.g. https://heartrhythmalliance.org/aa/uk/resources/arrhythmia-alliance-patient-resources). For the rest of the trial, they will follow the standard care pathway for ablation patients.
- Conditions
- Atrial Fibrillation
- Being tested
- Exercise Intervention, Education Intervention
- Keywords
- AF ablation, Pulmonary vein isolation, VO2peak
- Medical subject headings
- Atrial Fibrillation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise InterventionBehavioural
Exercise and education intervention. Participants will be prescribed a tailored exercise program to complete before ('pre-habilitation') and after their AF ablation procedure (rehabilitation).
Education InterventionBehavioural
Education intervention. Participants will be given a 1-1 education session (up to 3 sessions) before and after their AF ablation procedure. Participants will be given behavioural strategies to improve adherence and compliancec to risk-factor modification.
| Study group | Role | What they receive |
|---|---|---|
| Exercise Intervention | Experimental | Not described Receives: Behavioral: Exercise Intervention; Behavioral: Education Intervention |
| Standard Care | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
VO2 peak measurements
VO2peak measured from cardiopulmonary exercise testing (CPET) at baseline and 10 weeks (±2 weeks) post AF ablation between the standard care and intervention arms.
Measured: 12 months
Secondary outcomes (6)
Quality of life questionnaire
EQ-5D-5L questionnaire
Measured: 12 months
Quality of life questionnaire
SF-36 QoL Scale
Measured: 12 months
Quality of life questionnaire
Atrial Fibrillation Effect on Quality-of-Life (AFEQT)
Measured: 12 months
Cost effectiveness of CREED AF intervention
Incremental cost per quality adjusted life year (QALY).
Measured: 12 months
AF recurrence in short- and long-term
AF recurrence and burden from data collected from a 1-7-day(s) cardiac Holter monitoring at 10 weeks (±2 weeks) and 12 months (±4 weeks) post ablation, and requirement for redo-AF ablation as documented in medical records reviewed at 12 months post-ablation.
Measured: 12 months
Occurence of Major Adverse Cardiovascular Events (MACE)
MACE recorded at 12 months post-ablation
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Sep 2023
- Study start2 Nov 2023
- Primary completion30 Jun 2025
- Study completion30 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Atrial FibrillationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 107 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Faizel Osman, Principal investigator, University Hospitals Coventry & Warwickshre NHS Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06042231
- Sponsor's protocol ID
- FO596122
- Acronym
- CREED AF
- Status last verified
- Feb 2026
- First submitted
- 21 Aug 2023
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Chandan N, Matthews V, He H, Lachlan T, Lim VG, Joshi S, Hee SW, Noufaily A, Parkes E, Patel S, Andronis L, Shakespeare J, Eftekhari H, Ali A, McGregor G, Osman F. Cardiac prehabilitation, rehabilitation and education in first-time atrial fibrillation (AF) ablation (CREED AF): Study protocol for a randomised controlled trial. PLoS One. 2024 Oct 3;19(10):e0310951. doi: 10.1371/journal.pone.0310951. eCollection 2024.
PubMed 39361572
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Cardiac Prehabilitation, REhabilitation and Patient EDucation on Outcomes in Patients Undergoing First-time AF Ablation
- ClinicalTrials.gov ID
- NCT06042231
- Acronym / sponsor ID
- CREED AF / FO596122
- Conditions
- Atrial Fibrillation
- Keywords
- AF ablation, Pulmonary vein isolation, VO2peak
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 107 participants (actual)
- Lead sponsor
- University Hospitals Coventry and Warwickshire NHS TrustUniversity, hospital or other
- Study start
- 2 Nov 2023 (actual)
- Primary completion
- 30 Jun 2025 (actual)
- Study completion
- 30 Nov 2026 (estimated)
- First posted
- 18 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Atrial fibrillation (AF) is a term used to describe an irregular, and often very rapid, heartbeat. AF increases the risk of a number of diseases associated with the heart and cardiovascular system. Ablation is a procedure to treat AF. It uses small burns or freezes to cause some scarring on the inside of the heart to help break up the electrical signals that cause irregular heartbeats. This can help the heart maintain a normal rhythm.
Currently patients who are referred for AF ablation do not receive any additional support as part of standard care to improve the outcomes of their ablation procedure. Whereas cardiac rehabilitation is a recognised part of comprehensive care for coronary heart disease patients (patients whose hearts struggle to receive blood), with exercise and education consistently identified as central elements to their rehabilitation. This treatment is not yet recommended for AF ablation patients.
Therefore, the CREED AF Study is investigating whether a tailored comprehensive exercise and education intervention can improve outcomes in patients who are undergoing first time AF ablation. Central to the CREED AF study is the 'prehabilitation' intervention, whereby exercise and education training will be conducted before AND after AF ablation. 106 participants is the target recruitment, they will be randomised to either receive the CREED AF intervention (exercise and education intervention before AND after AF ablation) or a standard care (control) group. The standard care group will receive a one off 1-to-1 patient education session with a trained practitioner before their AF ablation procedure. This research study does not affect the AF ablation procedure that patients will have as part of their standard of care.
Detailed description
This is a single centre, prospective, randomised controlled trial. The CREED AF study will run from University Hospitals Coventry \& Warwickshire (UHCW) NHS Trust. There will be collaboration with Atrium Health, a non-profit exercise rehabilitation centre located in Coventry, UK. Atrium Health was founded by frontline NHS clinical staff to provide people with tailored exercise and education programmes. Patients with AF who are referred for first-time AF ablation at University Hospitals Coventry \& Warwickshire NHS Trust will be recruited to the trial. The aim is to explore the effectiveness of a tailored comprehensive cardiac rehabilitation programme (both before and after the planned AF ablation) comprising of an exercise programme and patient education programme incorporating lifestyle behaviour change (CREED AF intervention), compared to standard care (control arm).
The CREED AF intervention will involve a cardiac pre/rehabilitation exercise training programme combined with a patient education programme.
To ensure generalisability for future trials, provisions will be based on current delivery models of cardiac rehabilitation in cardiovascular diseases. A 6-8-week supported programme of 2-3 times weekly exercise will be delivered with an initial individual assessment for each patient randomised to the intervention. Participants will attend a one-to-one appointment with a 'CREED AF practitioner' (specialist cardio-pulmonary clinical exercise physiologist or physiotherapist) for the assessment of medical history, medication, clinical parameters, physical activity history and discussion of participant goals, expectations, fears, and concerns. Patients randomised to the CREED AF intervention will have access to both existing cardio-pulmonary rehabilitation programmes at the Atrium Health Centre, Coventry (i.e., they will exercise alongside people with a range of cardio-pulmonary disorders at already running sessions) AND instructor-led, at home workout sessions that will take place live over a video conferencing software. It is anticipated that participants randomised to the CREED AF intervention will choose to receive a hybrid of the two approaches to reduce travel constraints of getting to and from the Atrium Health Centre, and to work more flexibly around a participant's working/personal life. To maximise accessibility and resource, whilst ensuring benefits are retained, the CREED AF intervention will be delivered as a 'rolling' programme. Participants randomised to the CREED AF intervention can immediately join existing cardio-pulmonary rehabilitation exercise programmes rather than waiting for the recruitment of sufficient numbers to form a discrete group of trial participants.
Cardiac pre/rehabilitation This will be a tailored, individualised exercise programme within pre-specified parameters. Clinical information, data from the exercise assessment, and patient-centred goal setting will be used to devise a safe and effective exercise prescription which can be performed either using pre-existing cardiopulmonary exercise groups at Atrium Health or using the instructor-led online classes that will be available. Exercise guidance, specific to AF, will be delivered on an individual basis during a 1-to-1 familiarisation exercise session in the first week of the programme, and reinforced throughout, by clinical staff. Familiarisation sessions, conducted within the cardiopulmonary rehabilitation programmes will enable participants to build their confidence and there will be optimisation of the exercise prescribed.
The cardiac rehabilitation can be undertaken within existing cardio-pulmonary rehabilitation programmes delivered by NHS clinical staff. Up to 3 times weekly, one hour, exercise sessions for 6-8 weeks before and for 6-8 weeks after AF ablation, with a quantifiable and progressive dose of individualised, multi-modal, aerobic, muscular strength, endurance and 'functional fitness' exercise. Adequate warm-up and cool-down will be incorporated. Intensity can be monitored and adjusted using heart rate (where appropriate), rating of perceived exertion, and dyspnoea scale. There is normally a 1-2-week recovery period after an AF ablation procedure to allow for femoral access site wound healing. Only after the participant has completed this 2-week recovery period will they restart their exercise intervention.
The exercise component will be optimised to be appropriate for a broad spectrum of patients including frailer, deconditioned, low-mobility, exercise-naive participants. Conventional gym exercise will be combined with 'functional fitness' training. The programme will be highly adaptable to allow personalisation to lower or higher ability participants, whilst ensuring safety and efficacy. This is widespread practice within cardio-pulmonary rehabilitation programmes in the UK.
In addition to treadmills, cycles, and rowing ergometers, readily available functional fitness equipment such as steps, floor agility ladders, low rise balance beams, power bags, plyometric boxes, balls (throw/bounce) etc will be made use of. A range of body weight exercises for online sessions at home will also be utilised. Central to our intervention is the expertise and experience of the specialist CREED AF practitioner who will ensure holistic, safe, individualised, and effective exercise training.
Education, behavioural and lifestyle AF risk Factor Modification Support The education programme will be delivered in 1-to-1 sessions with a delegated and qualified member of the research team which can be delivered either face-to-face or via an online video conferencing software. The education session will be delivered as part of the CREED AF intervention. Changing behaviours can be difficult and the importance of psychological support in AF patients is recognised. Therefore, discussions with individuals on motivation to change, barriers to change, goal setting and problem-solving to build self-efficacy and encourage behaviour change, adherence, and compliance to risk factor modification will be incorporated. Every second week (a total of 6 1-to-1 education sessions, 3 sessions in prehabilitation before ablation, and 3 sessions in rehabilitation after ablation), before or after exercise, participants will receive a 1-to-1 30-minute behavioural and motivational session with the aim of improving short- and long-term adherence to exercise and lifestyle modification goals. The aim of this will be to provide help to patients to manage lifestyle risk factors. These will include reduction of alcohol consumption to less than 2 Units per day (in line with current UK government guidelines), ensure good blood pressure control in line with international guidelines (<140/85mmHg), provide smoking cessation support, help with good diabetes control, advice on weight reduction management (through diet and exercise) and identification and treatment of obstructive sleep apnoea (OSA). Patients in the intervention group will be provided with written materials, including but not limited to a patient workbook and publicly available patient information leaflets, with sign-posting to support groups as applicable to each individual.
The CPET will be performed by both the control and intervention groups at baseline and 10 weeks (±2 weeks) post-ablation. The test will be used to assess exercise capacity and will give an indicator of the participant's cardiorespiratory fitness. The tests will be performed at UHCW's respiratory laboratory. The lab is UKAS accredited to IQIPS standard to perform CPET. The local UHCW standard operating procedure for CPET will be followed for all participants during their VO2peak test. This information is available in full detail in a separate document, but briefly:
- The participant will have their height and weight measured and information about the current medications collected.
- They will have the procedure explained to them in full detail and any questions they have will be answered.
- A spirometry measurement of forced vital capacity will be obtained before the CPET begins.
- A 12-lead ECG will be attached to the participant.
- A Hans Rudolph face mask will be fitted to the participant and baseline data collected.
- A blood pressure cuff and pulse oximeter will be attached with measurements taken at baseline and during the test.
- The exercise protocol will begin with increasing exercise intensity until the participant feels they cannot continue, when cadence falls by 5% or more or when the individual leading the exercise test requests it to be stopped.
- Recovery period involving low intensity exercise.
Participants who are randomised into the control group will also receive a 30-minute 1-to-1 education session (remotely or in person) from a CREED AF practitioner before their AF ablation to go through the risk factors of AF and what they can do to improve their health. The session will involve a discussion with the participant around risk factors related to AF and recommendations for what actions the participant should take to minimise these factors, sign-posting to publicly available patient information leaflets (e.g. https://heartrhythmalliance.org/aa/uk/resources/arrhythmia-alliance-patient-resources). For the rest of the trial, they will follow the standard care pathway for ablation patients.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Exercise Intervention | Experimental | Behavioral: Exercise Intervention, Behavioral: Education Intervention |
| Standard Care | No intervention | – |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All patients listed for a first-time AF ablation procedure
- Patients aged ≥18 years
Key exclusion criteria (6 listed)
- Pregnancy
- Lack of capacity to consent and participate
- Presence of contraindications or limiting physical or mental health co-morbidity preventing travel, safe exercise, or productive engagement with the trial
- Unable to access online exercise and support sessions from home
- Participating in a research trial that will impact on their standard AF ablation procedure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise InterventionExercise and education intervention. Participants will be prescribed a tailored exercise program to complete before ('pre-habilitation') and after their AF ablation procedure (rehabilitation). | Behavioural | Exercise Intervention |
| Education InterventionEducation intervention. Participants will be given a 1-1 education session (up to 3 sessions) before and after their AF ablation procedure. Participants will be given behavioural strategies to improve adherence and compliancec to risk-factor modification. | Behavioural | Exercise Intervention |
Primary outcome
VO2 peak measurements
Time frame: 12 months
VO2peak measured from cardiopulmonary exercise testing (CPET) at baseline and 10 weeks (±2 weeks) post AF ablation between the standard care and intervention arms.
6 secondary outcomes
Quality of life questionnaire
Time frame: 12 months
Quality of life questionnaire
Time frame: 12 months
Quality of life questionnaire
Time frame: 12 months
Cost effectiveness of CREED AF intervention
Time frame: 12 months
AF recurrence in short- and long-term
Time frame: 12 months
Occurence of Major Adverse Cardiovascular Events (MACE)
Time frame: 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
- Derived from this study: PubMed 39361572Chandan N, Matthews V, He H, Lachlan T, Lim VG, Joshi S, Hee SW, Noufaily A, Parkes E, Patel S, Andronis L, Shakespeare J, Eftekhari H, Ali A, McGregor G, Osman F. Cardiac prehabilitation, rehabilitation and education in first-time atrial fibrillation (AF) ablation (CREED AF): Study protocol for a randomised controlled trial. PLoS One. 2024 Oct 3;19(10):e0310951. doi: 10.1371/journal.pone.0310951. eCollection 2024.
Related trials for Atrial Fibrillation
Active, not recruiting
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
Paroxysmal AF
Active, not recruitingObservational study
Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
Concomitant Procedures, Atrial Fibrillation
Active, not recruiting
CONVERGE Post-Approval Study (PAS)
Chronic Atrial Fibrillation
Recruiting
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Ischemic Stroke, Atrial Fibrillation
RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Faizel Osman principal investigator
University Hospitals Coventry & Warwickshre NHS Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise Intervention and Education Intervention in people with Atrial Fibrillation, run by University Hospitals Coventry and Warwickshire NHS Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
VO2 peak measurements (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06042231, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.